EUVIMEDOpdag EUVIMED
Crossref

Transcriptomics reveals apigenin alleviates airway inflammation and epithelial cell apoptosis in allergic asthma via MAPK pathway

Hang Yu, Xi Huang, Cong Xie, Jingrong Song, Yaolong Zhou, Hanlin Shi, Mengmeng Chen, Yueren Wu, Zhenhui Ruan, Lingling Deng, Xiaohong Deng, Yubao Lv and 2 more

Phytotherapy Research · 2023

DOI: 10.1002/ptr.7859 ↗

At a glance

Journal article in Phytotherapy Research, 2023. Written by Hang Yu and 13 co-authors. Institution: Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China. Major MEDLINE topics: Apigenin, Asthma. Cited 32 times so far (Crossref); 50 references. Funded by: Innovative research team of high-level local universities in Shanghai and a key laboratory program of the Education Commission of Shanghai Municipality, Shanghai Municipal Health Commission TCM Research Project, the National Key R&D Program of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Persistent chronic inflammation of the lungs and airway remodeling are important pathological features that cannot be ignored in patients with chronic asthma. Apigenin (API) is a natural small molecule compound with good anti‐inflammatory and antioxidant activity that has been widely reported in recent years, but its role in chronic asthma is not well defined. Our study began with oral gavage intervention using API (10, 20 mg/kg) or dexamethasone (DEX, 2 mg/kg) in a BALB/c mouse model of ovalbumin (OVA) sensitization. Different doses of API intervention effectively reduced airway resistance in the administered group. Additionally, inflammation was downregulated, mucus secretion was reduced, and airway remodeling was inhibited in the API intervention group compared with the model group. Asthma‐related inflammatory cytokines, such as IgE, IL‐4, IL‐5, IL‐13, and IL‐17, were downregulated in alveolar lavage fluid. Moreover, the apoptosis level of the administered group was found to be lower than that of the model group in the Tunel staining experiment. By analyzing transcriptome sequencing results, we found that API may exert anti‐inflammatory and anti‐apoptotic effects by inhibiting the MAPK pathway. Our subsequent results supported this conclusion, showing that the phosphorylation levels of ERKs, JNKs, and p38 MAPKs were inhibited in the administered group relative to the model group. Downstream expression of the apoptosis‐related protein B‐cell lymphoma‐2 (Bcl‐2) was upregulated, and the expression of Bcl‐2‐associated × protein (Bax) and cleaved caspase‐3 was downregulated. To further investigate the specific mechanism by which API acted, we established an in vitro model with house dust mite (HDM) stimulation, using API (10, 20 μM) for administration intervention. The results showed that API was able to improve cell viability, inhibit ROS production, and reverse HDM‐induced decreases in mitochondrial membrane potential (MMP) and apoptosis in airway epithelial cells via the MAPK pathway.

Subjects

MeSH terms (MEDLINE)

ApigeninAsthmaAnimalsMiceAirway RemodelingTranscriptomeInflammationAnti-Inflammatory AgentsApoptosisEpithelial CellsProto-Oncogene Proteins c-bcl-2

Author keywords

MAPKapigeninapoptosisasthmainflammationmitochondrial

Substances

ApigeninAnti-Inflammatory AgentsProto-Oncogene Proteins c-bcl-2

Authors and institutions

  • Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai, China.
  • Institute of Integrative Medicine, Fudan University, Shanghai, China.
  • Shanghai Key Laboratory of Bioactive Small Molecules, Fudan University, Shanghai, China.

ORCID profiles: Jingcheng Dong

Funding

  • Innovative research team of high-level local universities in Shanghai and a key laboratory program of the Education Commission of Shanghai Municipality
  • Shanghai Municipal Health Commission TCM Research Project
  • the National Key R&D Program of China
  • the National Natural Science Foundation of China
  • National Natural Science Foundation of China

Cite

APA

Yu, H., Huang, X., Xie, C., Song, J., Zhou, Y., Shi, H., Chen, M., Wu, Y., Ruan, Z., Deng, L., Deng, X., Lv, Y., Luo, Q., & Dong, J. (2023). Transcriptomics reveals apigenin alleviates airway inflammation and epithelial cell apoptosis in allergic asthma via MAPK pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.7859

Vancouver

Yu H, Huang X, Xie C, Song J, Zhou Y, Shi H, et al. Transcriptomics reveals apigenin alleviates airway inflammation and epithelial cell apoptosis in allergic asthma via MAPK pathway. Phytotherapy Research. 2023. doi:10.1002/ptr.7859

BibTeX
@article{Yu2023,
  author = {Yu, Hang and Huang, Xi and Xie, Cong and Song, Jingrong and Zhou, Yaolong and Shi, Hanlin and Chen, Mengmeng and Wu, Yueren and Ruan, Zhenhui and Deng, Lingling and Deng, Xiaohong and Lv, Yubao and Luo, Qingli and Dong, Jingcheng},
  title = {Transcriptomics reveals apigenin alleviates airway inflammation and epithelial cell apoptosis in allergic asthma via MAPK pathway},
  journal = {Phytotherapy Research},
  year = {2023},
  doi = {10.1002/ptr.7859}
}
Start for free →